Role of β-catenin in cisplatin resistance, relapse and prognosis of head and neck squamous cell carcinoma

ConclusionFrom our results we conclude that β-catenin may contribute to HNSCC therapy resistance and disease relapse. As such, β-catenin may be explored as a therapeutic target along with conventional therapeutics.
Source: Cellular Oncology - Category: Cancer & Oncology Source Type: research